These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 27699594

  • 1. Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception.
    Heffron R, Parikh UM, Penrose KJ, Mugo N, Donnell D, Celum C, Mellors JW, Baeten JM, Partners PrEP Study Team.
    AIDS Behav; 2017 Jul; 21(7):2173-2179. PubMed ID: 27699594
    [Abstract] [Full Text] [Related]

  • 2. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
    Jain AK.
    Contraception; 2012 Dec; 86(6):645-52. PubMed ID: 22541635
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, Bunge K, Ramjee G, Nair G, Palanee-Phillips T, Selepe P, van der Straten A, Parikh UM, Gomez K, Piper JM, Watts DH, Marrazzo JM, VOICE Study Team.
    Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
    Viola AS, Castro S, Bahamondes MV, Fernandes A, Viola CF, Bahamondes L.
    Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
    [Abstract] [Full Text] [Related]

  • 10. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
    Grabowski MK, Gray RH, Makumbi F, Kagaayi J, Redd AD, Kigozi G, Reynolds SJ, Nalugoda F, Lutalo T, Wawer MJ, Serwadda D, Quinn TC, Tobian AAR.
    Lancet Glob Health; 2015 Aug; 3(8):e478-e486. PubMed ID: 26094162
    [Abstract] [Full Text] [Related]

  • 11. Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States.
    Upadhyay UD, Zlidar VM, Foster DG.
    Contraception; 2016 Oct; 94(4):303-13. PubMed ID: 27326938
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased Cervical CD4+CCR5+ T Cells Among Kenyan Sex Working Women Using Depot Medroxyprogesterone Acetate.
    Lajoie J, Tjernlund A, Omollo K, Edfeldt G, Röhl M, Boily-Larouche G, Cheruiyot J, Kimani M, Kimani J, Oyugi J, Broliden K, Fowke KR.
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):236-246. PubMed ID: 30585733
    [Abstract] [Full Text] [Related]

  • 15. Changes in key vaginal bacteria among postpartum African women initiating intramuscular depot-medroxyprogesterone acetate.
    Whitney BM, Guthrie BL, Srinivasan S, Tapia K, Muriuki EM, Chohan BH, Wallis JM, Liu C, McClelland RS, Fredricks DN, Roxby AC.
    PLoS One; 2020 Mar; 15(3):e0229586. PubMed ID: 32134931
    [Abstract] [Full Text] [Related]

  • 16. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
    Morrison CS, Chen PL, Kwok C, Baeten JM, Brown J, Crook AM, Van Damme L, Delany-Moretlwe S, Francis SC, Friedland BA, Hayes RJ, Heffron R, Kapiga S, Karim QA, Karpoff S, Kaul R, McClelland RS, McCormack S, McGrath N, Myer L, Rees H, van der Straten A, Watson-Jones D, van de Wijgert JH, Stalter R, Low N.
    PLoS Med; 2015 Jan; 12(1):e1001778. PubMed ID: 25612136
    [Abstract] [Full Text] [Related]

  • 17. Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out.
    Hapgood JP.
    AIDS Res Hum Retroviruses; 2020 May; 36(5):357-366. PubMed ID: 31797677
    [Abstract] [Full Text] [Related]

  • 18. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
    Zalenskaya IA, Chandra N, Yousefieh N, Fang X, Adedipe OE, Jackson SS, Anderson SM, Mauck CK, Schwartz JL, Thurman AR, Doncel GF.
    J Clin Invest; 2018 Oct 01; 128(10):4622-4638. PubMed ID: 30222141
    [Abstract] [Full Text] [Related]

  • 19. Use of injectable hormonal contraception and HSV-2 acquisition in a cohort of female sex workers in Vancouver, Canada.
    Socías ME, Duff P, Shoveller J, Montaner JSG, Nguyen P, Ogilvie G, Shannon K.
    Sex Transm Infect; 2017 Jun 01; 93(4):284-289. PubMed ID: 27821613
    [Abstract] [Full Text] [Related]

  • 20. Depressive symptoms in users and non-users of depot medroxyprogesterone acetate.
    Civic D, Scholes D, Ichikawa L, LaCroix AZ, Yoshida CK, Ott SM, Barlow WE.
    Contraception; 2000 Jun 01; 61(6):385-90. PubMed ID: 10958882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.